1. Home
  2. CRBP vs BYFC Comparison

CRBP vs BYFC Comparison

Compare CRBP & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBP
  • BYFC
  • Stock Information
  • Founded
  • CRBP 2009
  • BYFC 1946
  • Country
  • CRBP United States
  • BYFC United States
  • Employees
  • CRBP N/A
  • BYFC N/A
  • Industry
  • CRBP Biotechnology: Pharmaceutical Preparations
  • BYFC Savings Institutions
  • Sector
  • CRBP Health Care
  • BYFC Finance
  • Exchange
  • CRBP Nasdaq
  • BYFC Nasdaq
  • Market Cap
  • CRBP 73.4M
  • BYFC 63.8M
  • IPO Year
  • CRBP N/A
  • BYFC 1996
  • Fundamental
  • Price
  • CRBP $6.45
  • BYFC $6.55
  • Analyst Decision
  • CRBP Strong Buy
  • BYFC
  • Analyst Count
  • CRBP 10
  • BYFC 0
  • Target Price
  • CRBP $53.56
  • BYFC N/A
  • AVG Volume (30 Days)
  • CRBP 147.8K
  • BYFC 11.2K
  • Earning Date
  • CRBP 05-06-2025
  • BYFC 04-28-2025
  • Dividend Yield
  • CRBP N/A
  • BYFC N/A
  • EPS Growth
  • CRBP N/A
  • BYFC N/A
  • EPS
  • CRBP N/A
  • BYFC N/A
  • Revenue
  • CRBP N/A
  • BYFC $32,732,999.00
  • Revenue This Year
  • CRBP N/A
  • BYFC N/A
  • Revenue Next Year
  • CRBP $150.00
  • BYFC N/A
  • P/E Ratio
  • CRBP N/A
  • BYFC N/A
  • Revenue Growth
  • CRBP N/A
  • BYFC N/A
  • 52 Week Low
  • CRBP $4.64
  • BYFC $4.41
  • 52 Week High
  • CRBP $61.90
  • BYFC $9.46
  • Technical
  • Relative Strength Index (RSI)
  • CRBP 46.87
  • BYFC 48.41
  • Support Level
  • CRBP $6.10
  • BYFC $6.36
  • Resistance Level
  • CRBP $8.07
  • BYFC $7.10
  • Average True Range (ATR)
  • CRBP 0.71
  • BYFC 0.36
  • MACD
  • CRBP -0.10
  • BYFC 0.01
  • Stochastic Oscillator
  • CRBP 13.31
  • BYFC 42.19

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: